ClinicalTrials.Veeva

Menu

Testosterone and Vascular Function in Reproductive-Aged Females With Chronic Kidney Disease

U

University of Calgary

Status

Completed

Conditions

Chronic Kidney Diseases
Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT06107166
REB18-0642

Details and patient eligibility

About

Cardiovascular disease (CVD) is the leading cause of death among women and women with chronic kidney disease are at an even greater risk of CVD. The aim of this observational study is to examine the relationship between total testosterone levels and measures of vascular function (pulse wave velocity, aortic augmentation index, flow mediated dilation and velocity time integral) in reproductive-aged women living with chronic kidney disease.

Enrollment

61 patients

Sex

Female

Ages

18 to 51 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female sex
  • a diagnosis of chronic kidney disease or end stage kidney disease
  • age 18-51

Exclusion criteria

Pregnancy, breastfeeding, current use of menopausal hormone therapy or gender affirming hormone therapy, or factors that would affect ovarian function, such as polycystic ovarian syndrome, premature ovarian insufficiency, ovarian malignancy, gonadotoxic chemotherapy, surgical oophorectomy, or previous radiation to the pelvis.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems